BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 12485499)

  • 41. The location of KIT and PDGFRA gene mutations in gastrointestinal stromal tumours is site and phenotype associated.
    Penzel R; Aulmann S; Moock M; Schwarzbach M; Rieker RJ; Mechtersheimer G
    J Clin Pathol; 2005 Jun; 58(6):634-9. PubMed ID: 15917417
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectrum and prognostication of KIT and PDGFRA mutation in gastrointestinal stromal tumors.
    Tzen CY; Wang MN; Mau BL
    Eur J Surg Oncol; 2008 May; 34(5):563-8. PubMed ID: 17532173
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [c-Kit and PDGFRA mutations and clinico-morphological features of gastrointestinal stromal tumors].
    Beliakov IS; Anurova OA; Snigur PV; Tsyganova IV; Sel'chuk VIu; Mazurenko NN
    Vopr Onkol; 2007; 53(6):677-81. PubMed ID: 18416137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity.
    Debiec-Rychter M; Wasag B; Stul M; De Wever I; Van Oosterom A; Hagemeijer A; Sciot R
    J Pathol; 2004 Apr; 202(4):430-8. PubMed ID: 15095270
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Malignant potential of gastrointestinal stromal tumor of the stomach.
    Aoyagi K; Kouhuji K; Yano S; Miyagi M; Imaizumi T; Takeda J; Shirouzu K
    Int Surg; 2009; 94(1):1-9. PubMed ID: 20099418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A recurrent duodenal gastrointestinal stromal tumor with a frameshift mutation resulting in a stop codon in KIT exon 13.
    Vu HA; Xinh PT; Kikushima M; Zhu Y; Tokuhara M; Tani M; Shimizu T; Saito K; Tokunaga K; Sato Y
    Genes Chromosomes Cancer; 2005 Feb; 42(2):179-83. PubMed ID: 15543597
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Familial gastrointestinal stromal tumor syndrome: phenotypic and molecular features in a kindred.
    Li FP; Fletcher JA; Heinrich MC; Garber JE; Sallan SE; Curiel-Lewandrowski C; Duensing A; van de Rijn M; Schnipper LE; Demetri GD
    J Clin Oncol; 2005 Apr; 23(12):2735-43. PubMed ID: 15837988
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel monoclonal antibody against DOG1 is a sensitive and specific marker for gastrointestinal stromal tumors.
    Espinosa I; Lee CH; Kim MK; Rouse BT; Subramanian S; Montgomery K; Varma S; Corless CL; Heinrich MC; Smith KS; Wang Z; Rubin B; Nielsen TO; Seitz RS; Ross DT; West RB; Cleary ML; van de Rijn M
    Am J Surg Pathol; 2008 Feb; 32(2):210-8. PubMed ID: 18223323
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.
    Haller F; Gunawan B; von Heydebreck A; Schwager S; Schulten HJ; Wolf-Salgó J; Langer C; Ramadori G; Sültmann H; Füzesi L
    Clin Cancer Res; 2005 Sep; 11(18):6589-97. PubMed ID: 16166437
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Protein kinase C theta is highly expressed in gastrointestinal stromal tumors but not in other mesenchymal neoplasias.
    Blay P; Astudillo A; Buesa JM; Campo E; Abad M; García-García J; Miquel R; Marco V; Sierra M; Losa R; Lacave A; Braña A; Balbín M; Freije JM
    Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4089-95. PubMed ID: 15217944
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diagnostic morphological features of PDGFRA-mutated gastrointestinal stromal tumors: molecular genetic and histologic analysis of 60 cases of gastric gastrointestinal stromal tumors.
    Daum O; Grossmann P; Vanecek T; Sima R; Mukensnabl P; Michal M
    Ann Diagn Pathol; 2007 Feb; 11(1):27-33. PubMed ID: 17240304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
    Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
    Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic assessment of gastrointestinal stromal tumor.
    Yan H; Marchettini P; Acherman YI; Gething SA; Brun E; Sugarbaker PH
    Am J Clin Oncol; 2003 Jun; 26(3):221-8. PubMed ID: 12796588
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor.
    Zheng S; Pan YL; Tao DY; Wang JL; Huang KE
    Scand J Gastroenterol; 2009; 44(6):760-3. PubMed ID: 19096980
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Distinct gene expression-defined classes of gastrointestinal stromal tumor.
    Yamaguchi U; Nakayama R; Honda K; Ichikawa H; Hasegawa T; Shitashige M; Ono M; Shoji A; Sakuma T; Kuwabara H; Shimada Y; Sasako M; Shimoda T; Kawai A; Hirohashi S; Yamada T
    J Clin Oncol; 2008 Sep; 26(25):4100-8. PubMed ID: 18757323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequent c-Kit gene mutations not only in gastrointestinal stromal tumors but also in interstitial cells of Cajal in surrounding normal mucosa.
    Ogasawara N; Tsukamoto T; Inada K; Mizoshita T; Ban N; Yamao K; Joh T; Itoh M; Tatematsu M
    Cancer Lett; 2005 Dec; 230(2):199-210. PubMed ID: 16297706
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Analysis of c-kit gene integrity in aplastic anemia.
    Paquette RL; Hsu NC; Koeffler HP
    Blood Cells Mol Dis; 1996; 22(2):159-68. PubMed ID: 8931956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The complexity of KIT gene mutations and chromosome rearrangements and their clinical correlation in gastrointestinal stromal (pacemaker cell) tumors.
    Andersson J; Sjögren H; Meis-Kindblom JM; Stenman G; Aman P; Kindblom LG
    Am J Pathol; 2002 Jan; 160(1):15-22. PubMed ID: 11786393
    [TBL] [Abstract][Full Text] [Related]  

  • 59. c-kit gene mutation at exon 17 or 13 is very rare in sporadic gastrointestinal stromal tumors.
    Kinoshita K; Isozaki K; Hirota S; Nishida T; Chen H; Nakahara M; Nagasawa Y; Ohashi A; Shinomura Y; Kitamura Y; Matsuzawa Y
    J Gastroenterol Hepatol; 2003 Feb; 18(2):147-51. PubMed ID: 12542597
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prognostic significance of c-kit mutation in localized gastrointestinal stromal tumors.
    Kim TW; Lee H; Kang YK; Choe MS; Ryu MH; Chang HM; Kim JS; Yook JH; Kim BS; Lee JS
    Clin Cancer Res; 2004 May; 10(9):3076-81. PubMed ID: 15131046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.